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Fractionated Laser Resurfacing Corrects the
Inappropriate UVB Response in Geriatric Skin
Dan F. Spandau1,2, Davina A. Lewis1, Ally-Khan Somani1 and Jeffrey B. Travers1,3,4,5
Non-melanoma skin cancer is a disease primarily afflicting geriatric patients as evidenced by the fact that 80% of
all non-melanoma skin cancers are diagnosed in patients over the age of 60 years. As such, geriatric skin
responds to cancer-inducing UVB irradiation in a manner that allows the establishment of tumor cells.
Currently, the only effective treatment for non-melanoma skin cancer is the removal of the tumors after they
appear, indicating the need for a more cost-effective prophylactic therapy. Geriatric volunteers were treated
with fractionated laser resurfacing therapy on either sun-protected (upper buttocks) or chronically sun-exposed
(dorsal forearm) skin. Fractionated laser resurfacing therapy was shown to decrease the occurrence of
senescent fibroblasts in geriatric dermis, increase the dermal expression of IGF-1, and correct the inappropriate
UVB response observed in untreated geriatric skin. These responses to fractionated laser resurfacing were
equal to the effects seen previously using the more aggressive wounding following dermabrasion. Furthermore,
fractionated laser resurfacing was equally effective in both sun-protected and sun-exposed skin. The ability of
fractionated laser resurfacing treatment to protect against the occurrence of UVB-damaged proliferating
keratinocytes indicates the potential of fractionated laser resurfacing to reduce or prevent aging-associated
non-melanoma skin cancer.
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INTRODUCTION
The annual incidence of non-melanoma skin cancer (NMSC)
is consistently the highest of all cancers worldwide (American
Cancer Society, 2010; Rogers et al., 2010). However, despite
intensive education efforts instructing individuals to avoid or
protect themselves against NMSC-inducing sun exposure, the
number of newly diagnosed NMSC lesions is still growing
each year (American Cancer Society, 2010). As such, the only
currently used effective treatment for NMSC is the removal of
the tumors after they appear. This type of reactive treatment
of NMSC is prohibitively expensive and can be traumatic and
disfiguring to patients. In fact, although the occurrence
of NMSC is only rarely life-threatening in the general
population, it is still the fifth most costly cancer to treat
(Housman et al., 2003; Bickers et al., 2006). Therefore, there
is an exquisite need for a prophylactic therapy that could
reduce the occurrence of NMSC, especially in highly susce-
ptible geriatric populations.
Clearly, NMSC is a disease primarily afflicting geriatric
patients as evidenced by the fact that only 20% of all NMSC
is diagnosed in patients under the age of 60 years (Kraemer,
1997; National Institutes of Health, 2010). Furthermore
NMSC, especially squamous cell carcinoma and actinic
keratosis, tends to only develop in areas of significant sun
exposure and significant solar damage (Higashi et al., 2004;
Lewis and Weinstock, 2004; Albert and Weinstock, 2005; de
Berker et al., 2007; Criscione et al., 2009; Weinstock et al.,
2009). The use of sunscreen and sun avoidance has been
demonstrated to protect against actinic neoplasia in geriatric
populations, indicating that this is an ongoing process and not
just the end result of previous sun exposure many years
earlier (Thompson and Marks, 1993; Naylor et al., 1995).
Recently, our laboratories have provided substantial evidence
that explains why geriatric patients have an increased
susceptibility to NMSC (Lewis et al., 2008a, 2010a, 2011).
The manner in which keratinocytes respond to UVB
irradiation is dependent on the activation of the IGF-1
receptor (IGF-1R) on epidermal keratinocytes (Kuhn et al.,
1999; Lewis et al., 2008b). Ligand-bound activated IGF-1R is
required in order for keratinocytes to respond appropriately to
UVB exposure (Kuhn et al., 1999; Lewis et al., 2008b).
Because human epidermal keratinocytes do not produce
IGF-1, the IGF-1R is primarily activated by IGF-1 produced
and secreted by adjacent fibroblasts in the papillary dermis.
Unfortunately, the expression of IGF-1 in the dermis
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diminishes with age because of an increasing population of
senescent fibroblasts (Lewis et al., 2010a). Therefore, the skin
of geriatric individuals is often deficient in IGF-1, leading to
insufficient activation of the IGF-1R in geriatric epidermal
keratinocytes (Lewis et al., 2010a, 2011). When exposed to
UVB radiation, this IGF-1 deficiency results in an inappropri-
ate response in epidermal keratinocytes, which could permit
the establishment of UVB-induced mutations in geriatric skin,
the initial step in the progression to NMSC (Albert and
Weinstock, 2005). In this regard, therapies that correct the
aging-associated silencing of IGF-1 expression should restore
the appropriate UVB response in geriatric skin and corre-
spondingly reduce the incidence of NMSC in this susceptible
population (Lewis et al., 2008a, 2010a).
Photorejuvenation techniques such as dermabrasion and
fractionated laser resurfacing (FLR) have been used for many
years to create more youthful-appearing skin (Ramos-e-Silva
and da Silva Carneiro, 2007; Friedman and Lippitz, 2009).
We have previously demonstrated that dermabrasion
of geriatric sun-protected skin can restore young adult
levels of IGF-1 expression and correct the inappropriate
UVB response that occurs in geriatric skin. These encoura-
ging results are tempered by the short-term traumatic effects
of dermabrasion on the patient’s skin. In contrast, FLR is
markedly less distressful to patients; in fact, the downtime in
patient activity following FLR is negligible. The present
studies examine the ability of wounding by FLR to decrease
the numbers of senescent fibroblasts, increase dermal IGF-1
levels, and protect against the production of keratinocytes
proliferating with UVB-induced DNA damage 24 hours
following exposure to a minimal erythema dose of UVB.
Furthermore, we have tested the effect of FLR on both aged
sun-protected skin and the more clinically relevant sun-
exposed skin. As these studies indicate that these photo-
rejuvenation procedures result in the complete reversal of the
geriatric inappropriate UVB response, they hold the potential
of protecting against actinic neoplasia.
RESULTS
Similar to dermabrasion, treatment of geriatric skin
with FLR increases collagen expression
One of the biological features of aging skin is the reduction of
collagen expression in geriatric skin as compared with
young adult skin (Fisher et al., 2008; Mine et al., 2008;
Farage et al., 2010). Previously, it has been demonstrated that
treating geriatric skin with dermabrasion greatly increases
the expression of type I collagen (Lewis et al., 2011).
However, dermabrasion therapy with removal of the entire
epidermis and the superficial papillary dermis has consider-
able morbidity and involves a recovery period (Figure 1a)
until the treated area has healed. In addition, dermabrasion
can result in scarring and have long-term pigmentary
changes. FLR is a less-ablative cosmetic therapy that avoids
both of these drawbacks associated with dermabraded skin
(Alexiades-Armenakas et al., 2008) (Figure 1a). To determine
whether treatment of geriatric skin with FLR increases
collagen 1 expression, geriatric volunteers were treated
with FLR on either sun-protected skin (upper buttocks) or
chronically sun-exposed skin (dorsal forearm) as described in
the Materials and Methods. At 3 months following FLR
treatment, the patients returned and punch biopsies were
obtained from FLR-treated skin and from adjacent untreated
skin. Collagen 1 expression was determined by quantitative
real-time reverse-transcriptase–PCR (QRT-PCR) analysis of
each biopsy. As shown in Figure 1b, the less invasive FLR
treatment increased collagen 1 expression in a manner
similar to that observed in dermabraded skin.
FLR decreases the relative number of senescent fibroblasts
in both sun-protected and sun-exposed geriatric skin
As skin ages, the papillary dermis in sun-protected skin has an
increasing proportion of senescent fibroblasts as compared
with young adult skin (Mine et al., 2008; Coppe et al., 2010).
To determine whether chronic sun exposure influenced the
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Figure 1. Fractionated laser resurfacing (FLR) increases collagen expression
in geriatric skin. (a) Sun-protected (upper buttocks) or sun-exposed (dorsal
forearm) geriatric (465 years old) volunteers were treated with dermabrasion
(DA) or FLR. Images shown were obtained immediately following treatment.
(b) Relative COL1A expression was assayed by quantitative real-time
reverse-transcriptase–PCR (QRT-PCR) (standardized by actin expression) from
biopsies obtained from sun-protected skin from young adult (20–28 years old)
volunteers, sun-protected skin from geriatric volunteers, healed (3 months)
sun-protected skin from geriatric patients treated with DA, healed (3 months)
sun-protected skin from geriatric patients treated with FLR, and healed
(3 months) sun-exposed skin from geriatric patients treated with FLR. Error
bars indicate standard error of mean (SEM); asterisks indicate significant
difference from geriatric control values (Po0.05, Student’s t-test). Young
adult, n¼ 4; geriatric control, n¼ 23; geriatric DA, n¼6; geriatric FLR sun-
protected, n¼6; and geriatric FLR sun-exposed, n¼ 7. Note: Young adult and
geriatric DA data are presented in this figure for comparison; similar data have
been previously reported in another format (Lewis et al., 2008a, 2010b).
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accumulation of senescent fibroblasts, biopsies from geriatric
sun-protected skin and sun-exposed skin were assayed
for markers of senescent fibroblasts (as shown in Figure 2a).
Previously, histological changes in photodamaged skin
included an increase in the proportion of senescent
fibroblasts (Fisher et al., 2008). Surprisingly in our studies,
no differences in the proportion of senescent fibroblasts were
observed in untreated sun-protected geriatric skin versus
sun-exposed geriatric skin, indicating that intrinsic aging
appears to be as important as extrinsic aging in the studied
population (Supplementary Figure S1A online). To determine
whether FLR could reduce the percentage of senescent
fibroblasts in geriatric skin, volunteers were treated as
described above (both sun-protected and sun-exposed skin),
and the treated biopsies were assayed for markers of
senescent fibroblasts (Figure 2a). Following FLR treatment,
the percentage of senescent fibroblasts was significantly
reduced in both sun-protected and sun-exposed skin. In fact,
the reduction in senescent fibroblasts in FLR-treated
sun-protected skin was significantly greater than that seen
in dermabraded sun-protected skin (Figure 2b; geriatric
dermabrasion vs. geriatric FLR (sun-protected); P¼0.013,
Student’s t-test).
FLR restores the appropriate UVB response in geriatric skin
while increasing dermal IGF-1 expression
As previously described, sun-protected geriatric skin exhibits
an aberrant pro-carcinogenic UVB response because of IGF-1
silencing in senescent geriatric keratinocytes. To date, we
have only examined the effects of chronological aging on
sun-protected skin so that actinic damage did not influence
our interpretation of those results. However, UVB-induced
skin cancer only occurs on sun-exposed skin (Albert and
Weinstock, 2005), which necessitated a comparison of the
UVB response on sun-protected and sun-exposed skin.
Geriatric volunteers were UVB-irradiated either on their
upper buttocks (sun-protected skin) or on their dorsal forearm
(sun-exposed skin). At 24 hours post-UVB irradiation, bio-
psies of the irradiated skin and the adjacent unirradiated
skin were collected and assayed for IGF-1 expression and the
UVB response (Lewis et al., 2010a). No significant differences
were observed for IGF-1 expression, UVB-induced
DNA damage (a crude marker of DNA repair), or in the
inappropriate UVB response between sun-exposed and sun-
protected skin (Supplementary Figure S1 online), indicating
based on these parameters that the UVB response of
sun-protected and sun-exposed geriatric skin is equivalent.
Treatment of geriatric skin with dermabrasion corrects the
inappropriate UVB response and increases IGF-1 signaling in
geriatric papillary dermis (Lewis et al., 2011). In addition,
dermabrasion has been shown to be an effective treatment
and prophylactic therapy for NMSC (Benedetto et al., 1992;
Coleman et al., 1996). However, the physical and psycho-
logical consequences of dermabrasion treatment render it
impractical for widespread use in NMSC therapy. Therefore,
the ability of the less-ablative FLR treatment to influence the
UVB response in geriatric skin was evaluated. Using the
subject biopsies described above, the expression of IGF-1
was measured via QRT-PCR (Figure 3a; Lewis et al., 2010a)
and the number of basal layer keratinocytes containing
both UVB-induced DNA damage and replication proteins
(Figure 3b; Lewis et al., 2010a) were determined at 24 hours
post-UVB irradiation (Lewis et al., 2010a, 2011). FLR
treatment on either sun-protected or sun-exposed skin
significantly increased IGF-1 expression in the geriatric
dermis. In fact, the level of IGF-1 expression in FLR-treated
skin was indistinguishable from that of young adult controls
(Figure 3a; Lewis et al., 2010a). Furthermore, FLR treatment
virtually eliminated the inappropriate UVB response shown
in matched geriatric control tissue. This reduction in
the inappropriate UVB response exceeds that previously
observed in dermabraded geriatric skin (Figure 3b; Lewis
et al., 2011). FLR treatment does not significantly increase the
volume of epidermal or papillary dermis tissue (Supplemen-
tary Figure S2A online); however, similar to dermabrasion,
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Figure 2. Fractionated laser resurfacing (FLR) decreases the proportion of
senescent fibroblasts found in geriatric skin. (a) Biopsies from untreated
control geriatric skin and geriatric skin treated with FLR (following 3 months
of healing) were stained with antibodies to p53 binding protein 1 (53BP1) and
40,6-diamidino-2-phenylindole (DAPI). Senescent fibroblasts in the dermis are
identified by their persistent expression of 53BP1. Bar¼ 50mm. (b) The
percentage of senescent fibroblasts in the papillary dermis of the indicated
skin samples was determined by quantifying the number of 53BP1(þ ) cells
in relation to the total number of DAPI(þ ) fibroblasts. Image analysis was
performed as described in the Materials and Methods using the Nikon
Elements software (Nikon Instruments, Melville, NY). Error bars indicate
standard error of mean (SEM); asterisks indicate significant difference from
geriatric control values (Po0.006, Student’s t-test). Young adult, n¼ 3;
geriatric control, n¼ 22; geriatric dermabrasion (DA), n¼6; geriatric FLR
sun-protected, n¼6; and geriatric FLR sun-exposed, n¼ 7.
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FLR treatment does increase the density of fibroblasts in the
papillary dermis of sun-exposed skin (Supplementary Figure
S2B online; Lewis et al., 2011). Furthermore, FLR treatment
appears to reverse the age-dependent decrease in
UVB-induced DNA repair response seen in geriatric skin
(Supplementary Figure S3 online). The number of basal layer
keratinocytes containing UVB-induced DNA lesions at
24 hours post-irradiation in dermabraded skin is statistically
the same as the elevated number observed in untreated
geriatric epidermis (Supplementary Figure S3 online).
In contrast, FLR-treated geriatric skin has similar low numbers
of keratinocytes containing UVB-damaged DNA at the same
time point as found in young adult skin. These data indicate
that FLR treatment more than exceeds the previously
described corrective ability of dermabrasion in restoring the
appropriate UVB response in geriatric skin. However, FLR
has the added benefit of obtaining the desired results without
the extensive tissue damage associated with dermabrasion
treatment (Figure 1a; Friedman and Lippitz, 2009).
The number of photodamaged keratinocytes in chronically
sun-exposed skin is reduced by FLR
Chronically sun-exposed skin in geriatric patients has been
shown to have actinically damaged keratinocytes, which
can be identified by overexpression of the p53 protein
(El-Domyati et al., 2007). To determine the effect of FLR
treatment on these damaged keratinocytes, matched pairs of
control and FLR-treated geriatric skin biopsies were analyzed
for p53 expression (example shown in Figure 4a). As seen in
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Figure 3. Fractionated laser resurfacing (FLR) increases dermal IGF-1
expression and restores the appropriate UVB response in geriatric skin.
(a) IGF-1 gene expression was measured by quantitative real-time reverse-
transcriptase–PCR (QRT-PCR) analysis of biopsies from volunteers described
in Figure 1b and standardized to actin expression. Error bars indicate standard
error of mean (SEM); asterisk denotes statistical significance of geriatric
control values from all other cohorts (Po0.02; individual paired t-test).
In addition, analysis of variance (ANOVA) detected no significant difference
between young adult, geriatric dermabrasion (DA), and geriatric FLR cohorts.
Young adult, n¼4; geriatric control, n¼ 27; geriatric DA, n¼ 6; geriatric
FLR sun-protected, n¼ 8; and geriatric FLR sun-exposed, n¼ 8. (b) The skin
samples from the patient cohorts described in Figure 1 were assayed for
their response to UVB irradiation by quantifying the level of basal layer
keratinocytes in the biopsies that had detectable UVB-induced DNA damage
(TD(þ )) and cellular markers of proliferation (Ki67(þ )) at 24 hours following
an exposure to UVB. Error bars indicate SEM; asterisk denotes statistical
significance of geriatric control values from all other cohorts (Po0.001;
individual paired t-test). In addition, ANOVA detected no significant
difference between young adult, geriatric DA, and geriatric FLA cohorts.
Young adult, n¼ 6; geriatric control, n¼ 27; geriatric DA, n¼ 7; geriatric FLR
sun-protected, n¼ 7; and geriatric FLR sun-exposed, n¼ 8. Note: Young adult
and geriatric DA data are presented in this figure for comparison; similar data
have been previously reported in another format (Lewis et al., 2008a, 2010b).
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Figure 4. Fractionated laser resurfacing (FLR) reduces the number of
chronically photodamaged keratinocytes in sun-exposed geriatric skin. The
expression of the tumor suppressor p53 in the keratinocytes of sun-exposed
skin was used as a surrogate marker of chronic photodamage often found in
geriatric patients. Matched tissue biopsies from individual patients, one from
untreated dorsal forearm and a second from dorsal forearms treated with FLR
(3 months following the procedure), were assayed for the expression of p53
using immunohistochemistry, a is an example of one of these matched biopsy
sets. Bar¼ 50 mm. (b) The relative expression of p53 was determined for each
set of biopsies described in a using the Nikon Elements Image Analysis
software. Error bars indicate standard error of mean (SEM); asterisks indicate
significant difference from untreated geriatric control values (Po0.002,
Student’s t-test; n¼ 12).
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Figure 4b, FLR treatment decreased the expression of p53 as
compared with control untreated tissue. These data indicate
that in addition to correcting the inappropriate UVB response
in geriatric skin, FLR also reduces the proportion
of endogenous actinically damaged keratinocytes in sun-
exposed geriatric epidermis.
DISCUSSION
Previously, we have demonstrated that geriatric skin lacks
the ability to respond appropriately when exposed to the
wavelengths of UVB found in sunlight, as compared with the
ability of younger skin (Lewis et al., 2010a). Almost certainly,
this failure to adequately cope with UVB-damaged keratino-
cytes in geriatric skin contributes to the increased suscept-
ibility of elderly individuals to NMSC by enhancing the
likelihood of UVB-induced mutations in epidermal keratino-
cytes (Lewis et al., 2008a, 2010b). As this aberrant response
to UVB exposure is due to the accumulation of senescent
fibroblasts in geriatric dermis (Lewis et al., 2010a), a
reduction in the proportion of senescent fibroblasts should
correct the inappropriate UVB response in geriatric skin, and
therefore could reduce the incidence of aging-associated
NMSC (Lewis et al., 2008a, 2010b). We now report that the
treatment of geriatric skin with FLR therapy reduces the
percentage of senescent fibroblasts in geriatric papillary
dermis and, more importantly, restores the appropriate
UVB response of geriatric keratinocytes. Furthermore, we
have demonstrated that FLR therapy is effective on both
sun-protected and chronically sun-exposed geriatric skin. By
inducing a mild wound healing response, FLR therapy
increases the percentage of replicating fibroblasts in the
papillary dermis. These newly recruited youthful fibroblasts
actively produce new collagens that partially accounts for the
cosmetic benefits of FLR on geriatric skin. In addition, the
new fibroblasts also have increased expression of IGF-1 that
serves to correct the IGF-1 deficiency seen in untreated
geriatric skin. This restoration of adequate IGF-1 expression
in geriatric skin is responsible for correcting the inappropriate
UVB response in geriatric keratinocytes.
These findings are important because treating NMSC,
particularly highly susceptible geriatric populations, has a
high economic burden on our healthcare system, in part
because of the need for multiple surgical treatments over
many years (Housman et al., 2003; Bickers et al., 2006). The
development of a prophylactic therapy that could be used on
at-risk actinically damaged skin could substantially reduce
the overall treatment costs of NMSC. Interestingly, there have
been isolated reports and small studies that indicate that
cosmetic wounding techniques, including FLR and dermab-
rasion, have been used to treat existing NMSC (Halachmi and
Lapidoth, 2008; Choudhary et al., 2011). In fact, dermabra-
sion has also been reported to successfully prevent the
recurrence of actinic keratosis and NMSC (Field, 2007);
however, the extensive cutaneous damage inherent with
dermabrasion therapy is often unacceptable (Field, 2007).
In contrast, the specific FLR treatment used in this study has
none of the debilitating secondary effects seen in dermabra-
sion therapy. More importantly, in our studies, FLR treatment
was equal if not superior to dermabrasion in correcting the
inappropriate UVB response in geriatric skin.
Although our previous studies have provided a potential
mechanism for the protective effects of dermabrasion
treatment on the prevention of actinic keratosis and NMSC,
we can now suggest that other wounding modalities, such as
FLR, may have similar protective effects by decreasing the
proportion of senescent fibroblasts in geriatric dermis,
upregulating IGF-1 expression, and reversing the inappropri-
ate UVB response. Although the benefits of FLR on at-risk
geriatric skin will need to be studied further, these data
indicate the potential of relatively benign FLR treatment
to reduce or prevent aging-associated NMSC.
MATERIALS AND METHODS
Human volunteers
Geriatric volunteers (aged 65 years and above) were recruited from
patients treated at dermatology clinics within the Indiana University
Medical Center (Supplementary Table SI online). The studies
have the approval of the Indiana University School of Medicine
Institutional Review Board in accordance with the Declaration of
Helsinki Principles. Specific requirements for inclusion and exclu-
sion criteria can be found in the Supplementary Materials online.
Fractionated laser resurfacing
All subjects were thoroughly briefed on the risks and benefits of
participating in the study and they signed an informed consent
statement attesting to their willful participation. Geriatric volunteers
who met the criteria for inclusion in this study were divided into
two cohorts, one group was treated with FLR on sun-protected
skin (upper buttocks), whereas the second group was treated on
chronically sun-exposed skin (dorsal forearm). Members of each
cohort underwent wounding of a small 5 5 cm2 area of either the
upper buttocks or dorsal forearm with two passes at 12% coverage
using 120mJ of energy per microspot (Pearl Fractional Laser; Cutera,
Brisbane, California) without anesthesia. The Pearl Fractional Laser
is a 2,790 nm yittrium scandium gallium garnet ablative fractional
resurfacing device that thermally ablates microscopic columns of
epidermal and dermal tissue in regularly spaced arrays. Patients
were given wound care instructions and asked to return in 3 months.
Human UVB response assay
On return, a localized area 1 1 cm2 of either FLR-treated skin or
untreated normal skin (on the opposite hip/buttock or forearm) was
irradiated with dose of 350 J/m2 of UVB. In Fitzpatrick Skin Types I
and II, this dose of UVB is sufficient to cause a minimal
erythematous reaction. A permanent marker was used to outline
the areas of skin that were irradiated. At 24 hours following UVB
exposure, photographs were taken of the skin to document the extent
of the UVB reaction. A portion of the irradiated skin and unirradiated
adjacent skin was removed by punch biopsy (4-mm punch biopsies
of the UVB-treated skin and 3-mm punch biopsies of unirradiated
skin; 4 biopsies per individual). The epidermal response to UVB
irradiation was assayed as described previously (Lewis et al., 2010a,
2011). Briefly, thin paraffin-embedded sections from unirradiated
and UVB-irradiated biopsies were simultaneously stained with
antibodies to Ki67 and thymine dimers. Secondary antibodies that
specifically detect only one of the primary antibodies were
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conjugated to the fluorescent dyes AlexaFluor 488 (detecting Ki67,
emitting green wavelengths) and AlexaFluor 568 (detecting thymine
dimers, emitting red wavelengths). Images were captured
sequentially along the entire length of the biopsy specimen (3mm
unirradiated, 4mm irradiated) using a Nikon Eclipse 80i microscope
with Intensilight epifluorescence. These images were analyzed by
counting the number of keratinocytes in contact with the basement
membrane that are Ki67(þ ), thymine dimer(þ ), and Ki67(þ ):thy-
mine dimer(þ ). These numbers were expressed as a percentage of
total basal layer keratinocytes in the biopsy specimen (determined
by counting basal layer keratinocytes for each specimen on
hematoxylin- and eosin-stained slides).
Statistical analysis
All statistical analyses were carried out by two-tailed Student’s t-test.
Statistical significance was defined as Po0.05, unless otherwise
noted in the figure legend. Analysis of variance (ANOVA) was used
to compare multiple cohorts.
Supporting information
Three additional figures, a table, and specific protocols for
quantitative reverse-transcription PCR, immunofluorescence, quanti-
fication of senescent fibroblasts, UVB irradiation, and immunohis-
tochemistry can be found in the Supplementary Material online. In
addition, methods and materials for the previously presented data
shown in Figures 1 and 3 are provided in the Supplementary Material
online.
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